Effects of Oral Administration of Moringa oleifera Lam on Glucose Tolerance in Goto-Kakizaki and Wistar Rats by Ndong, Moussa et al.
229
Original Article J. Clin. Biochem. Nutr., 40, 229–233, May 2007
Effects of Oral Administration of Moringa oleifera Lam on Glucose 
Tolerance in Goto-Kakizaki and Wistar Rats
Moussa Ndong, Mariko Uehara, Shin-ichi Katsumata, and Kazuharu Suzuki*
Department of Nutritional Science, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 
Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan
Received 4 December, 2006; Accepted 27 December, 2006
Summary Medicinal plants constitute an important source of potential therapeutic agents for
diabetes. In the present study, we investigated the effects of Moringa oleifera (MO) Lam,
Moringacea, on glucose tolerance in Wistar rats and Goto-Kakizaki (GK) rats, modeled type
2 diabetes. Major polyphenols in MO powder were quercetin glucosides, rutin, kaempferol
glycosides and chlorogenic acids by HPLC analysis. As the results of glucose tolerance test, MO
significantly decreased the blood glucose at 20, 30, 45and 60 min for GK rats and at 10, 30 and
45 min for Wistar rats (p<0.05) compared to the both controls after glucose administration.
The area under the curve of changes in the blood glucose was significantly higher in the GK
control group than in the GK plus MO group (p<0.05) in the periods 30–60 min and 60–
120 min. Furthermore, MO significantly decreased stomach emptying in GK rats (p<0.05).
The results indicated that MO has an ameliorating effect for glucose intolerance, and the effect
might be mediated by quercetin-3-glucoside and fiber contents in MO leaf powder. The action
of MO was greater in GK rats than in Wistar rats.
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Introduction
Diabetes is a chronic metabolic disorder with impaired
glucose tolerance and high risk of cardiovascular disease [1].
Many oral synthetic antidiabetic agents have been developed
[2]. Hyperglycemia can be handled initially with oral agents
and insulin therapy, which is sometimes required to achieve
targeted glycemic levels. However, these synthetic agents
produce some serious side effects and are relatively expensive
for developing countries [3]. Therefore, searching for effective,
low cost and less side effected hypoglycemic agents is
important. Herbal remedies for diabetes are known since
ancient times in different societies. Scientific data supported
the antidiabetic effects of some medicinal plants [4]. Moringa
oleifera (MO) Lam (drumstick tree and horseradish tree)
belongs to Moringacea family witch accounts 14 species.
MO is widely distributed in the tropics. MO has anti-cancer
[5], anti-inflammatory [6] and thyroid status regulator [7]
efficacies, and some researchers reported its hypoglycemic
potential [8]. The aim of the present study was to examine
the effects of MO on glucose tolerance in Goto-Kakizaki
(GK) and normal Wistar rats. The GK rat is a relevant model
to understand and study the human type 2 diabetes. The GK
rat is obtained by selective breeding of normal Wistar rats,
using glucose tolerance as the selection index [9]. In the
early stages of the disease, GK rats do not present severe
associated complications as compared to obese diabetic rats.
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Thus, they are very useful for understanding the onset of
human type 2 diabetes.
Materials and Methods
Animals and diets
The MO leaves were harvested from different trees in the
south region of Senegal. The leaves were dried in shade and
pounded to yield a powder. Male spontaneously diabetic GK
rats (body weight (BW): 150–170 g) and non-diabetic male
Wistar rats as the control (BW: 190–210 g) were obtained
from the Clea Japan, Inc. (Tokyo, Japan). The rats were
housed in individual stainless cages in a temperature and
humidity controlled room with a 12 h light/dark cycle. The
animals were allowed free access to deionized water and the
AIN 93G based diet during one week for acclimatization.
Then, animals were randomly divided into two groups:
control GK (G) and GK plus MO (GM). Control Wistar (C)
and Wistar plus MO (CM) were also used for determining
glucose tolerance in normal condition. This study was
approved by the Tokyo University of Agriculture Animal
Use Committee, and rats were maintained in accordance
with the guidelines of the University for the Care and Use of
Laboratory Animals.
Polyphenol analysis in MO
The types of polyphenols in MO leaf powder were
determined by HPLC with photodiode array detector
(Hitachi, Tokyo, Japan) [10].
Determination of blood glucose
After over night food privation, fasting blood glucose
(BG) was determined and oral glucose tolerance test (OGTT)
was performed with glucose D (+) (Kanto Chemical Co.,
INC, Tokyo, Japan). The control groups (C, G) received a
single dose of glucose (2 g/kg BW), whereas a single dose of
the solution glucose-MO (2 g/kg BW and 200 mg MO leaf
powder/kg BW, respectively) was administered to MO
groups (CM, GM). Blood glucose was reported at 10, 20, 30,
45, 60, 90 and 120 min via the tail vein with a blood glucose
test meter (Medisafe-mini GR-102, TERUMO Co., Tokyo,
Japan). The areas under the curve (AUC) of changes in the
blood glucose were calculated by the following formula:
AUC = Σ{[(Cn − Co)+( Cn+1 − C0)] × (tn+1 − t0)]}
Weighing contents of stomach and intestine
At the end, the rats were anesthetized with diethyl ether,
and blood was taken and centrifuged at 3,000 rpm for
15 min to obtain serum. The stomach, the small intestine and
the caecum were taken, weighted and opened. Their contents
were washed out with water, dried and weighted again. Their
contents were estimated by weight differences.
Statistics
Data are expressed as means ± SEM. Two-way ANOVA
was used to determine the main effects of MO and the time
course, and their interaction in the changes of blood glucose
in each strain. Significant differences between the groups
were determined by Fischer’s PLSD test (SPSS version
14.0J, SPSS, Chicago, IL). Differences were considered
significant at p<0.05.
Results and Discussion
There were no significant differences on the body weight
(GK: 190–192 g, Wistar: 207–208 g) between the two
groups in both GK and Wistar rats. The Fig. 1 represents
the results of the OGTT in GK rats. The initial BG (0 min)
was 126.7 ± 1.5 mg/dl for the both two groups. The final
BG (120 min) was 273.3 ± 14.0 and 272.8 ± 11.2 mg/dl for
the G and GM, respectively. The two-way ANOVA showed
that the two main effects of MO and time course, and also
the interaction (MO and time course) were significant
(p<0.05) for BG changes. MO significantly decreased BG at
20, 30, 45, and 60 min (p<0.05) compared to the control.
The Fig. 2 represents the results of the OGTT in Wistar rats.
The initial BG (0 min) was 91.6 ± 5.4 and 96.0 ± 3.1 mg/dl
for the C and CM, respectively. The final BG (120 min)
was 125.4 ± 6.1 and 129.8 ± 5.8 mg/dl for the C and CM,
respectively. The two-way ANOVA showed that the two
main effects (MO and time course) were significant (p<0.05)
for OGTT. However, no significant interaction was found
between these two factors for the BG changes. A significant
difference in BG between the C and CM groups was noted at
10 30 and 45 min (p<0.05) after glucose administration.
These results suggest that MO has a glucose intolerance
ameliorating effect in both GK and Wistar rats. Furthermore,
Fig. 1.  Time course changes of blood glucose in GK rats after a
single dose of a glucose or a glucose-MO solution.
Values are means ± SEM, n = 6. Asterisk at a particular
time point determines significant difference between the
G and GM group, p<0.05.Moringa Oleifera and Glucose Tolerance
Vol. 40, No. 3, 2007
231
MO’s action was greater in GK rats than in Wistar rats.
The Table 1 shows the AUC of BG levels in GK and
Wistar rats. The two-way ANOVA showed that the main two
effects (MO and time course) were significant (p<0.05), but
the interaction was not significant for AUC. For GK rats, the
AUC was significantly lower in the GM group than in the G
group (p<0.05) in the periods 30–60 min and 60–120 min.
The total AUC was also significantly lower in the GM group
than in the G group (p<0.05). For Wistar rats, the two-way
ANOVA showed a significant effect in the factor of time
course (p<0.05). On the basis of BG level of the CM group
compared to the control (C), no significant differences were
noted during the periods 0–30 min, 30–60 min and 60–
120 min after the administration. After an oral ingestion of
glucose, the maintenance of glucose tolerance depends on the
insulin secretion, the hepatic glucose production, the glucose
absorption rate in the digestive tract and the glucose uptake
by peripheral tissues. Impaired insulin secretion or insulin
resistant in GK rats explains the glucose intolerance of
these animals. The restitution of insulin secretion in GK
rats normalizes the defective glucose responsiveness [11].
Although serum insulin was not determined in this study, but
MO may influence the secretion and action of insulin like
other plant products [12, 13].
The dark chocolate polyphenols [14] and some other
polyphenols [15, 16] were described as hypoglycemic agents.
We analyzed polyphenols in the MO leaf powder. The analysis
showed a high concentration of quercetin-3-glycoside (Q-3-G:
1494.2 µmol/100 g dry weight(dw)), rutin (1446.6 µmol/100 g
dw), kaempferol glycosides (394.4 µmol/100 g dw), and other
polyphenols were almost chlorogenic acid (134.5 µmol/100 g
dw). In plants and most plant-derivated foods, flavonoids are
largely present as conjugates with the flavonoid linked to a
variable sugar moiety by a beta-glycosidic bond [17]. Q-3-G
was reported to be more bioavailable than the quercetin
aglycone [18]. From these findings, the involvement of the
intestinal sodium glucose transporter-1 (SGLT-1) in the
absorption of quercetin glucosides was suggested [19, 20].
Ader et al. [21] suggested that quercetin glucosides named
Q3G (isoquercitrin) and quercetin-4'-glucoside (spiraeosid)
competitively inhibit sodium (Na+) dependent mucosal
uptake of the non-metabolisable glucose analogue methyl-
α-D-glucopyranoside via SGLT-1 using rat mid-jejunum,
whereas quercetin (aglycone) and rutin had no effect.
Furthermore, Cermak et al. [22], in a similar experiment
with SGLT-1-containing brush-border-membrane vesicles from
porcine jejunum, have shown that Q3G inhibits not only
Na+-dependent glucose uptake but also Na+-independent,
non-saturable uptake of glucose. They suggest that this
uptake component could be due to passive glucose diffusion
or to glucose transport via a Na+-independent carrier, which
does not saturate at the glucose concentrations used in their
study. The hypoglycemic effect of kaempferol-3,7-O-(α)-
dirhamnoside (kaempferitrin) has been also reported by using
alloxan-induced diabetic rats [23]. Thus, MO flavonoids,
especially Q3G, might affect glucose uptake by intestinal
mucosa and therefore affect the time course of appearance of
glucose in the blood and their availability to other parts of
the body.
Our results showed that MO tended to retain longer the
food consumption in the stomach (Table 2). The weight of
stomach contents of the GM group was significantly higher
Fig. 2.  Time course changes of blood glucose in Wistar rats
after a single dose of a glucose or a glucose-MO
solution. Values are means ± SEM, n = 5. Asterisk at a
particular time point determines significant difference
between the C and CM group, p<0.05.
Table 1. Blood glucose calculated from areas under the courves of blood concentrations at specific
time periods
GK Wistar
GG M CC M
0–30 min 5506.6 ± 309.9 4621.6 ± 203.9 1429.0 ± 126.7 1152.0 ± 33.0
30–60 min 7916.2 ± 298.0 6522.5 ± 221.5* 1543.5 ± 152.6 1339.5 ± 181.0
60–120 min 11227.5 ± 500.9 10207.5 ± 364.4* 2595.0 ± 408.4 2694.0 ± 565.2
Total 24650.4 ± 838.5 21351.6 ± 499.8* 5567.5 ± 646.7 5185.5 ± 750.1
Values are means SEM, n = 6 (GK) or 5 (Wistar). Asterisk at a particular time point determines
significant difference between the G and GM group, p<0.05.M. Ndong et al.
J. Clin. Biochem. Nutr.
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than that of the G group, and the weight tended to be higher
in the CM group than the C group, whereas no significant
differences were found for the weights of small intestine and
caecum contents between the two groups in both GK and
Wistar rats. Rapid gastric emptying rates would result in
increased absorption of food factors, and therefore a higher
postprandial glycemia would be observed. The delay of
gastric emptying may play an important role in glycemic
control in diabetes. Slowing the stomach emptying can
improve glycemia control by prolonging the postprandial
absorption. Thus, MO might decrease the velocity of gastric
emptying, a major determinant of postprandial glycemia
[24]. Some herbal medicines were reported to inhibit gastric
emptying and also glucose uptake in the small intestine [25].
High fiber diets decrease postprandial blood glucose by
slowing the rate of food passage from the stomach to the
small intestine [26]. Other fibers from rice and soybean
decrease plasma glucose after glucose loading in diabetic
rats [27]. MO leaf powder contains around 4% of fiber.
We speculated hypoglycemic effect of MO might be due
to an inhibition of glucose uptake with Q3G and slowing
gastric emptying with fiber in MO leaf powder, although
other active components [27, 28] are existed in MO.
In conclusion, we investigated the effects of oral adminis-
tration of MO leaf powder on glucose tolerance in GK and
Wistar rats. Our results showed that MO has a glucose
intolerance ameliorating effect in both GK and Wistar rats,
although the action of MO was greater in GK rats than in
Wistar rats. The MO’s action might be mediated by Q3G
and fiber contents. However, further studies are needed to
identify the certain active components of MO for glucose
intolerance ameliorating action.
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